Patient- and physician-related risk factors for hyperkalaemia in potassium-increasing drug–drug interactions

Author： Eschmann Emmanuel   Beeler Patrick   Kaplan Vladimir   Schneemann Markus   Zünd Gregor   Blaser Jürg  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.70, Iss.2, 2014-02, pp. : 215-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Drug–drug interactions of antifungal agents and implications for patient care

By Gubbins Paul O   Amsden Jarrett R  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2231-2243

Informa Healthcare

Access to resources Recommend Favorite

Clinical Risk Management in Dutch Community Pharmacies: The Case of Drug-Drug Interactions

By Buurma Henk   De Smet Peter A.G.M   Egberts Antoine C.G.  

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite

A Human Drug Metabolism Database: Potential Roles in the Quantitative Predictions of Drug Metabolism and Metabolism-Related Drug-Drug Interactions

By  

Current Drug Metabolism, Vol. 4, Iss. 5, 2003-10 ,pp. : 411-422

Bentham Science Publishers

Access to resources Recommend Favorite

Maraviroc potential drug-drug interactions

By  

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Transporter-mediated drug––drug interactions

By Müüller Fabian   Fromm Martin F  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 1017-1037

Future Medicine

Access to resources Recommend Favorite